longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

532

532
0.0020.00%( 0.000 )

LongbridgeAI

DISA unit to trial AI-powered community eye screening in Vietnam with OneMedic

Tip Ranks
Feb 11, 2026 at 09:43 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

DISA Limited's subsidiary, Digital Life Line, has partnered with OneMedic in Vietnam to conduct a pilot for AI-powered community eye screening. This initiative aims to address the lack of specialist eye care in rural areas by integrating portable vision screening devices into OneMedic's AI healthcare platform. The pilot, set to begin in February 2026, will evaluate the effectiveness of this approach and create a vision health dataset for public health planning. Currently, DISA's stock is rated as a Sell with a price target of S$0.01.

Valentine's Day Sale - 70% Off

  • Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
  • Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

DISA ( (SG:532) ) just unveiled an announcement.

Digital Life Line, a subsidiary of DISA Limited, has signed a memorandum of understanding with Vietnam-based OneMedic to run a proof-of-concept pilot for AI-powered community vision screening. The collaboration aims to integrate DLL’s portable Automated Visual Acuity Test and MIDAS cataract screening devices into OneMedic’s AI healthcare platform to address a shortage of specialist eye care and limited clinic infrastructure in rural areas.

The pilot will test the feasibility and effectiveness of delivering fast, accurate and scalable eye screening through an integrated, portable workflow deployed in community healthcare settings. It also seeks to generate a comprehensive vision health dataset from underserved populations in Vietnam, supporting evidence-based public health planning and potentially strengthening DISA’s position in AI-enabled healthcare solutions when the project begins, targeted for February 2026, subject to final implementation terms.

The most recent analyst rating on (SG:532) stock is a Sell with a S$0.01 price target. To see the full list of analyst forecasts on DISA stock, see the SG:532 Stock Forecast page.

More about DISA

DISA Limited is a Singapore-listed technology group focused on deploying cutting-edge innovations such as artificial intelligence and the Internet of Things to improve outcomes, reduce costs and boost efficiency in the healthcare and consumer sectors. Through strong in-house research and development, the company develops scalable digital solutions and connected devices that support the digitalisation of products and services across its target markets.

Current Market Cap: S$14.09M

Learn more about 532 stock on TipRanks’ Stock Analysis page.

Login to unlock1,482characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

DISA

DISA

532.SG

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--